BiotechTube
Home/Jasper Therapeutics/Anna French, Ph.D.
AF

Anna French, Ph.D.

Chief Operating Officer

Jasper Therapeutics

Therapeutic Areas

HematologyImmunologyGenetic DisordersOncology

Jasper Therapeutics Pipeline

DrugIndicationPhase
Briquilimab (JSP191)Conditioning for HSCT in Severe Combined Immunodeficiency (SCID)Phase 1/2 / Pivotal Path

Leadership Team at Jasper Therapeutics

RM
Ronald Martell
President and Chief Executive Officer
WW
Wen-Kai Weng, M.D., Ph.D.
Chief Medical Officer
SH
Scott Harris
General Counsel
ET
Edwin Tucker, M.D.
Chief Financial Officer
HB
Heather Behanna, Ph.D.
SVP, Investor Relations & Corporate Communications
View full Jasper Therapeutics profile